Use of antipsychotic drugs among residents with dementia in European long-term care facilities: results from the SHELTER study.

[1]  S. Patten,et al.  Diagnostic data for neurological conditions in interRAI assessments in home care, nursing home and mental health care settings: a validity study , 2013, BMC Health Services Research.

[2]  M. Mitka.  CMS seeks to reduce antipsychotic use in nursing home residents with dementia. , 2012, JAMA.

[3]  T. Lai,et al.  Caregiver burden associated with behavioral and psychological symptoms of dementia (BPSD) in Taiwanese elderly. , 2012, Archives of gerontology and geriatrics.

[4]  Gabriele Meyer,et al.  Prevalence of psychotropic medication use among German and Austrian nursing home residents: a comparison of 3 cohorts. , 2012, Journal of the American Medical Directors Association.

[5]  Harriet Finne-Soveri,et al.  Assessment of nursing home residents in Europe: the Services and Health for Elderly in Long TERm care (SHELTER) study , 2012, BMC Health Services Research.

[6]  F. Verhey,et al.  Prescribing pattern of psychotropic drugs in nursing home residents with dementia , 2011, International Psychogeriatrics.

[7]  L. V. Van Bortel,et al.  Assessment of antipsychotic prescribing in Belgian nursing homes , 2011, International Psychogeriatrics.

[8]  S. Ryu,et al.  Persistence of neuropsychiatric symptoms over six months in mild cognitive impairment in community-dwelling Korean elderly , 2010, International Psychogeriatrics.

[9]  Denys T. Lau,et al.  Unexplained variation across US nursing homes in antipsychotic prescribing rates. , 2010, Archives of internal medicine.

[10]  A. Noro,et al.  Measuring the quality of long-term institutional care in Finland. , 2010 .

[11]  N. Ikegami,et al.  Use of physical restraints and antipsychotic medications in nursing homes: a cross‐national study , 2009, International journal of geriatric psychiatry.

[12]  J. Hirdes,et al.  Sharing clinical information across care settings: the birth of an integrated assessment system , 2009, BMC health services research.

[13]  C. Ballard,et al.  The dementia antipsychotic withdrawal trial (DART-AD): long-term follow-up of a randomised placebo-controlled trial , 2009, The Lancet Neurology.

[14]  J. Hirdes,et al.  Reliability of the interRAI suite of assessment instruments: a 12-country study of an integrated health information system , 2008, BMC health services research.

[15]  John P Hirdes,et al.  The Aggressive Behavior Scale: A New Scale to Measure Aggression Based on the Minimum Data Set , 2008, Journal of the American Geriatrics Society.

[16]  P. Rochon,et al.  Variation in nursing home antipsychotic prescribing rates. , 2007, Archives of internal medicine.

[17]  H. Alanen.  Antipsychotic Use among Older persons in Long-Term Institutional and Home Care , 2007 .

[18]  L. Pekkarinen,et al.  Nursing Working Conditions in Relation to Restraint Practices in Long-Term Care Units , 2006, Medical care.

[19]  F. Verhey,et al.  A prospective study of the effects of behavioral symptoms on the institutionalization of patients with dementia , 2005, International Psychogeriatrics.

[20]  Jalpa A Doshi,et al.  The quality of antipsychotic drug prescribing in nursing homes. , 2005, Archives of internal medicine.

[21]  H. Wong,et al.  The impact of neuropsychiatric symptoms of dementia on distress in family and professional caregivers in Singapore , 2005, International Psychogeriatrics.

[22]  Geoff M. Anderson,et al.  Neuroleptic Drug Therapy in Older Adults Newly Admitted to Nursing Homes: Incidence, Dose, and Specialist Contact , 2004, Journal of the American Geriatrics Society.

[23]  V. Mor,et al.  The use of atypical antipsychotics in nursing homes. , 2003, The Journal of clinical psychiatry.

[24]  N. Herrmann.  Recommendations for the Management of Behavioral and Psychological Symptoms of Dementia , 2001, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[25]  J N Morris,et al.  Development of a minimum data set-based depression rating scale for use in nursing homes. , 2000, Age and ageing.

[26]  B E Fries,et al.  Scaling ADLs within the MDS. , 1999, The journals of gerontology. Series A, Biological sciences and medical sciences.

[27]  M. Pahor,et al.  A brief training program on resident assessment instrument improves motivation of nursing home staff. , 1999, The journal of nutrition, health & aging.

[28]  D. Mehr,et al.  MDS Cognitive Performance Scale. , 1994, Journal of gerontology.

[29]  B. O’Donnell,et al.  Incontinence and Troublesome Behaviors Predict Institutionalization in Dementia , 1992, Journal of geriatric psychiatry and neurology.

[30]  G A Chase,et al.  Psychiatric symptoms and nursing home placement of patients with Alzheimer's disease. , 1990, The American journal of psychiatry.

[31]  I. Katz,et al.  The Psychiatric Symptoms of Alzheimer's Disease , 1988, Journal of the American Geriatrics Society.

[32]  J. Cohen-Mansfield,et al.  Agitated Behaviors in the Elderly: I. A Conceptual Review , 1986, Journal of the American Geriatrics Society.